The rates of ERα high-expression in normal ovary, serous cystadenoma, serous borderline tumor, and ovarian serous adenocarcinoma were 61.1, 45.7, 34.9 and 16.4%, respectively (Table S3). This evidence concerns the gene ESR1 and serous cystadenoma.